Cytomx Therapeutics shares owned by Geode Capital Management
Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in Cytomx Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cytomx Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Cytomx Therapeutics by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.0M | 1.6M | 3.19 |
| 2025-06-30 | $4.0M | 1.7M | 2.27 |
| 2025-03-31 | $546k | 858k | 0.64 |
| 2024-12-31 | $840k | 816k | 1.03 |
| 2024-09-30 | $948k | 804k | 1.18 |
| 2024-06-30 | $939k | 770k | 1.22 |
| 2024-03-31 | $1.6M | 753k | 2.18 |
| 2023-09-30 | $873k | 676k | 1.29 |
| 2023-06-30 | $1.1M | 644k | 1.72 |
| 2023-03-31 | $970k | 642k | 1.51 |
| 2022-12-31 | $964k | 603k | 1.60 |
| 2022-09-30 | $851k | 588k | 1.45 |
| 2022-06-30 | $1.1M | 583k | 1.83 |
| 2022-03-31 | $2.8M | 1.1M | 2.67 |
| 2021-12-31 | $5.1M | 1.2M | 4.33 |
| 2021-09-30 | $5.7M | 1.1M | 5.09 |
| 2021-06-30 | $7.3M | 1.2M | 6.33 |
| 2021-03-31 | $8.3M | 1.1M | 7.73 |
| 2020-12-31 | $5.0M | 758k | 6.55 |
| 2020-09-30 | $5.0M | 753k | 6.65 |
| 2020-06-30 | $5.9M | 709k | 8.33 |
| 2020-03-31 | $5.4M | 705k | 7.67 |
| 2019-12-31 | $5.5M | 656k | 8.31 |
| 2019-09-30 | $4.6M | 617k | 7.38 |
| 2019-06-30 | $6.7M | 599k | 11.22 |
| 2019-03-31 | $6.4M | 597k | 10.75 |
| 2018-12-31 | $8.6M | 567k | 15.10 |
| 2018-09-30 | $9.5M | 514k | 18.50 |
| 2018-06-30 | $8.3M | 363k | 22.86 |
| 2018-03-31 | $9.4M | 330k | 28.42 |
| 2017-12-31 | $7.3M | 348k | 21.08 |
| 2017-09-30 | $5.8M | 326k | 17.70 |
| 2017-06-30 | $3.6M | 235k | 15.50 |
| 2017-03-31 | $3.6M | 209k | 17.27 |
| 2016-12-31 | $2.1M | 192k | 10.98 |
| 2016-09-30 | $2.8M | 181k | 15.68 |
| 2016-06-30 | $777k | 76k | 10.21 |
| 2016-03-31 | $880k | 68k | 12.89 |
| 2015-12-31 | $1.2M | 58k | 20.85 |